摘要 |
Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia secondary to or associated with non-dialysis dependent chronic kidney disease anemia associated with or resulting from chemotherapy, or anemia associated with AIDS. |
申请人 |
AKEBIA THERAPEUTICS, INC. |
发明人 |
SMITH, Alexander;CHANDORKAR, Gurudatt, Ajay;ETTE, Ene, Ikpong;MARONI, Bradley, John;HARTMAN, Charlotte, Suzanne;FARZANEH-FAR, Ramin;INRIG, Jula, Kern |